Full Year 2025 Nanosonics Ltd Earnings Call Transcript
Key Points
- Nanosonics Ltd (NNCSF) achieved a 17% growth in revenue for FY25, reaching $198.6 million, which was at the top end of their upgraded guidance.
- The company reported a 20% growth in recurring revenue from consumables and services, totaling $146.1 million.
- Gross profit margin improved to 78.2%, demonstrating strong profitability.
- Nanosonics Ltd (NNCSF) secured FDA clearance for CORIS and launched new products, trophon3 and trophon2 Plus, enhancing their product portfolio.
- The company achieved significant sustainability milestones, sourcing 100% renewable energy for its operations, reducing Scope 2 emissions by 56%.
- The company anticipates a gross margin decline to between 75% and 77% in FY26 due to a $4 million impact from tariffs.
- Operating expenses increased by 10% to $138.7 million, with significant investments in R&D and infrastructure.
- The company faces challenges in the Japanese market, with slow progress despite some encouraging signs.
- Minimal revenue is expected from the CORIS controlled market release in FY26, indicating a slow commercialization process.
- The company will incur additional costs due to the relocation of its premises, including $10 million to $12 million in capital expenditure over the next two years.
Hello, and welcome, everyone, to the Nanosonics full-year results FY25 Investor Briefing. My name is Catherine Strong, and I've joined the Nanosonics team here as Head of Investor Relations. (Event Instructions) There will be a presentation of the FY25 results from Michael Kavanagh, Chief Executive Officer and President; and Jason Burriss, Chief Financial Officer.
During the presentation, the management team will speak to a selection of the slides that we lodged earlier this morning with the ASX. The webinar will show the relevant slide on the screen. However, if you join by conference call only, may we recommend that you follow the webinar in addition. (Event Instructions) I would now like to hand over the call to Michael Kavanagh. Please go ahead, Michael.
Thanks very much, Catherine, and a very good morning, everybody, and thank you all for joining the call. Well, by now, you will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

